Pay in 4 interest-free payments of $5.84 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Metabolic alkalosis
The escalation timelines differ
4 Single-dose vials Discard unused portion Lilly PACKAGE LABEL - Zepbound Single-Dose Vial - 10 mg/0.5 mL Dose NDC 0002-1340-04 Zepbound (tirzepatide) injection 10 mg/0.5 mL Rx Only For Subcutaneous Use Needles and Syringes are not included Dispense enclosed Medication Guide to each patient
Retatrutide is an investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors, not yet approved by the MHRA or EMA, with Phase 3 trials ongoing
These results reaffirm previous study conclusions about GSH, MDA, and cytokine levels between healthy and T2DM individuals ( Preclinical Results: Intracellular Survival of M
US$ 26.50
US$ 25.39
US$ 20.54
US$ 26.30
US$ 25.31
US$ 21.38
US$ 21.29
US$ 26.62
US$ 24.96
US$ 27.62
US$ 25.80
